Sicor Takes a Turn for the Better, Posts $4.4-Million Quarterly Profit
- Share via
Sicor Inc., an Irvine pharmaceutical company, reported fourth-quarter net income of $4.4 million, or 5 cents a share. That contrasts with a year-earlier net loss of $13.9 million, or 17 cents a share, which included a pretax charge of $3.7 million for the divestment of Gensia Automedics. Revenue advanced 50% to $65.2 million.
For the year, the company posted net income of $5.7 million, or 7 cents a share, contrasted with a net loss of $24.6 million, or 31 cents a share, for the prior year. Revenue increased 28% to $229 million.
Inside the business of entertainment
The Wide Shot brings you news, analysis and insights on everything from streaming wars to production — and what it all means for the future.
You may occasionally receive promotional content from the Los Angeles Times.
